Michael Feigh
Impact in
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
-
- Regulation of Appetite and Obesity
Papers in
- Epidemiology 48
- Liver Disease Diagnosis and Treatment 45
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Diabetes Treatment and Management 13
- Diet, Metabolism, and Disease 2
- Co-authors
- Sanne Skovgård Veidal (29 shared papers)Niels Vrang (18 shared papers)Henrik H. Hansen (21 shared papers)Jacob Jelsing (13 shared papers)Kristoffer T.G. Rigbolt (3 shared papers)K.S. Tølbøl (10 shared papers)Kristoffer T. G. Rigbolt (9 shared papers)Keld Fosgerau (2 shared papers)
- Journals
- Journal of Hepatology (10 papers)Diabetes (7 papers)Scientific Reports (4 papers)Hepatology Communications (3 papers)British Journal of Pharmacology (3 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Michael Feigh
61 papers receiving 2k citations
Michael Feigh's Hit Papers
Peers
Comparison fields: 5 of 75
- Epidemiology 1.2k
- Endocrine and Autonomic Systems 143
- Endocrinology, Diabetes and Metabolism 371
- Hepatology 152
- Pharmacology 100
Countries citing papers authored by Michael Feigh
This map shows the geographic impact of Michael Feigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Feigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Feigh more than expected).
Fields of papers citing papers by Michael Feigh
This network shows the impact of papers produced by Michael Feigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Feigh. The network helps show where Michael Feigh may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Feigh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis Hit paper breakdown → | 2020 | 226 |
| 2 | 2016 | 215 | |
| 3 | 2017 | 209 | |
| 4 | An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) Hit paper breakdown → | 2024 | 142 |
| 5 | 2018 | 122 | |
| 6 | 2021 | 111 | |
| 7 | 2016 | 110 | |
| 8 | 2019 | 105 | |
| 9 | 2020 | 100 | |
| 10 | 2018 | 67 | |
| 11 | 2022 | 66 | |
| 12 | 2014 | 65 | |
| 13 | 2019 | 45 | |
| 14 | 2020 | 45 | |
| 15 | 2022 | 42 | |
| 16 | 2011 | 41 | |
| 17 | 2021 | 37 | |
| 18 | 2015 | 32 | |
| 19 | 2021 | 28 | |
| 20 | 2023 | 27 |
About Michael Feigh
Michael Feigh is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems, Surgery and Molecular Biology, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (45 papers), Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (7 papers), Regulation of Appetite and Obesity (7 papers), Fibroblast Growth Factor Research (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Diet, Metabolism, and Disease (2 papers). The work is most often cited by research in Epidemiology (1.2k citations), Endocrine and Autonomic Systems (143 citations), Endocrinology, Diabetes and Metabolism (371 citations), Hepatology (152 citations) and Pharmacology (100 citations). Michael Feigh has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Sanne Skovgård Veidal, Niels Vrang, Henrik H. Hansen, Jacob Jelsing, Kristoffer T.G. Rigbolt, K.S. Tølbøl, Kristoffer T. G. Rigbolt, Keld Fosgerau, Jonathan David Roth and Kim Henriksen. Their work appears in journals such as Journal of Hepatology, Diabetes, Scientific Reports, Hepatology Communications and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.